Search results
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 hours agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 day agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 1 day agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 7 hours agoDebt Management: BioNTech's debt-to-equity ratio is below the industry average at 0.01 , reflecting a lower dependency on debt financing and a more conservative financial.
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 day agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks· 5 days agoThis suggests that analysts have very recently bumped up their estimates for BNTX, giving the stock a Zacks Earnings ESP of +123.61%heading into earnings season. A positive ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 2 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
Kestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 3 days agoKestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the 4th quarter, according to the company in its most...with ...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 2 days agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 5 days agoThe fund owned 108,696 shares of the company’s stock after selling 17,318 shares during the period. Van ECK Associates Corp’s holdings in BioNTech were ...